Lion TCR Gains NMPA Approval for mRNA TCR-T Therapy GZL-016 in HCC
CompanyDrug

Lion TCR Gains NMPA Approval for mRNA TCR-T Therapy GZL-016 in HCC

BeiGene to Rebrand as BeOne Medicines, Emphasizing Global Commitment to Cancer Care
Company

BeiGene to Rebrand as BeOne Medicines, Emphasizing Global Commitment to Cancer Care

Eli Lilly's Tirzepatide Shows Sustained Weight Loss in 176-Week Study
CompanyDrug

Eli Lilly’s Tirzepatide Shows Sustained Weight Loss in 176-Week Study

GE Healthcare's SIGNA MAGNUS MRI Scanner Receives FDA 510(k) Clearance
CompanyMedical Device

GE Healthcare’s SIGNA MAGNUS MRI Scanner Receives FDA 510(k) Clearance

Cullgen and Pulmatrix Merge to Form Nasdaq-Listed Protein Degradation Company
CompanyDeals

Cullgen and Pulmatrix Merge to Form Nasdaq-Listed Protein Degradation Company

ImmuneOnco Initiates Phase II Study for IMM27M in ER+ Advanced Breast Cancer
CompanyDrug

ImmuneOnco Initiates Phase II Study for IMM27M in ER+ Advanced Breast Cancer

Huadong Medicine's Biosimilar SaiLeXin Receives First National Prescription in China
CompanyDrug

Huadong Medicine’s Biosimilar SaiLeXin Receives First National Prescription in China

Zucara Therapeutics Secures $20M Series B Financing Led by Sanofi and PXV Fund
CompanyDeals

Zucara Therapeutics Secures $20M Series B Financing Led by Sanofi and PXV Fund

Novartis' Pluvicto Accepted for Review by China's NMPA for Prostate Cancer Treatment
CompanyDrug

Novartis’ Pluvicto Accepted for Review by China’s NMPA for Prostate Cancer Treatment

Daiichi Sankyo and AstraZeneca File BLA for Datopotamab Deruxtecan in NSCLC
CompanyDrug

Daiichi Sankyo and AstraZeneca File BLA for Datopotamab Deruxtecan in NSCLC

Zhejiang Dian Diagnostics Partners with SNN/CRHA for Optic Nerve Disease Research
CompanyDeals

Zhejiang Dian Diagnostics Partners with SNN/CRHA for Optic Nerve Disease Research

BioNTech Seals Acquisition of China's Biotheus for Up to $950M
CompanyDeals

BioNTech Seals Acquisition of China’s Biotheus for Up to $950M